AI brief of an SEC Form 8-K · American Healthcare REIT (AHR)

American Healthcare REIT posts Q4 profit of $10.8 million; 2026 NFFO guide $1.99-$2.05

Positive Impact 3 of 5 earnings Written later

American Healthcare REIT reported fourth quarter and full year 2025 results on February 26, 2026, showing a swing to net income from prior-year losses and higher Normalized FFO per diluted share. The company also issued 2026 guidance for Normalized FFO of $1.99 to $2.05 per diluted share, with a $2.02 midpoint, compared with $1.72 in 2025. The guidance does not assume any transactions or capital markets activity beyond those already completed.

Key points

  • Q4 2025 GAAP net income attributable to controlling interest was $10.8 million, or $0.06 per diluted share, versus a loss of $31.8 million, or $0.21 per share, in Q4 2024.
  • Full-year 2025 GAAP net income attributable to controlling interest was $69.8 million, or $0.42 per diluted share, versus a loss of $37.8 million, or $0.29 per share, in 2024.
  • Normalized FFO was $0.46 per diluted share in Q4 2025 versus $0.40 a year earlier, and $1.72 for 2025 versus $1.41 in 2024; total portfolio same-store NOI grew 11.8% in Q4 and 14.2% for the year.
  • 2026 guidance calls for net income of $0.75 to $0.81 per diluted share and total portfolio same-store NOI growth of 7.0% to 11.0%.

The filing

CompanyAmerican Healthcare REIT (AHR)
Form8-K, current report
Filed with the SECFeb 26, 2026, 4:20 PM ET
Accession number0001193125-26-076786

Items reported: 2.02 Results of Operations7.01 Regulation FD Disclosure

Read the filing on SEC.gov ↗

Written by AI on Nov 8, 2026, 1:12 AM ET, from this filing only. Written later: this filing was briefed after the fact, when past filings were added to the site, so the brief may be read with hindsight; the filing itself is the record of what was known on February 26, 2026.

Briefs are written by AI from the filing text and can contain mistakes — open the filing before acting on anything. Impact (1-5) and tone are the AI's reading of the filing for shareholders, not a price forecast. Not investment advice.